7 things that happen when you walk for 10 minutes after each meal, as per Harvard-trained Gastroenterologist

7 things that happen when you walk for 10 minutes after each meal, as per Harvard-trained Gastroenterologist

The practice of walking after meals is a basic health-boosting habit, which many underestimate. However, a brief post-dinner walk produces multiple health advantages, which include enhanced blood sugar management, better digestion and improved sleep quality. Scientific studies from recent years demonstrate that walking after meals, helps people control their weight, and protects their heart health…

Read More
If you start taking the new weight-loss medications, be ready to stay with it for a long time, says Dr V Mohan, Chennai-based senior diabetologist who has worked extensively on the epidemiology and genetics of the disease. Excerpts from his chat with TOI, which is partnering with Novo Nordisk India to spearhead the ‘Choose Your Weight’ campaign, which aims to change the narrative around obesity.Q: You have watched the evolution of weight-loss drugs through five decades of practice. Did you think they would emerge as such blockbuster drugs?A: Efforts to develop effective weight-reduction medicines have been on for decades. In the late 80s and 90s, drugs such as sibutramine, phentermine and orlistat were introduced that facilitated modest weight loss of 1kg or 2kg, and rarely around 5kg. Some of these drugs had major side-effects and were eventually banned. We, as physicians, began to lose hope that any drug would come along that could offer significant weight loss without significant side-effects.Then, we started getting drugs such as the GLP-1 receptor analogs (GLP-1RAs). Exenatide was the first; it came from the venom of a Gila monster in South America, and ensured significant weight loss than earlier drugs. Initially, we didn’t know how they worked, but they delayed gastric emptying and increased insulin release and glucagon reduction… They work through the potentiation of certain hormones in the intestine called GLP, the glucagon-like peptide. Researchers tried to make glucagon-like peptide itself, but it was very short-acting in the body. So, they started producing GLP-like substances.Exenatide was followed by liraglutide. We found these mainly anti-diabetic drugs offered a two-in-one response by helping people reduce weight. Not everyone responded the same way; some had both weight reduction and HbA1c reduction, others had only one; a small percentage had neither. Then came semaglutide, which took the world by storm. Semaglutide was a weekly injection marketed as Ozempic for diabetes and Wegovy for weight loss. It got approved in the US separately for weight loss and diabetes, marking the first time an anti-diabetic drug was used solely for weight loss. It became a blockbuster drug with billions in sales, and millions started using it due to its unprecedented weight loss results, often 10-15 kg. The drug became so popular that it was hard to find, and new factories had to be built to meet the demand. Celebrities started using it, and before-and-after pictures were circulated widely. They were sold on the black market. This kind of success story with any drug had never been seen in the history of medicine.Q: But there are concerns about their side-effects…A: These drugs, including liraglutide and exenatide, work on the stomach, causing nausea initially. They must be started at a small dose and gradually increased to minimise side-effects. After four to eight weeks, side-effects such as nausea, vomiting, or diarrhoea usually settle.Stomach paralysis is a rare side-effect. Another rare but serious side effect is blindness due to anterior ischemic optic neuropathy. One in 7,000-10,000 people who take these drugs can go blind. Such rare side-effects will surface only when millions start taking a drug. It’s like the Covid vaccination: as mass vaccination was carried out, we saw side-effects. We don’t know why those idiosyncratic reactions occur, but we must remember there’s no big FDA warning so far. Clearly, its benefits far outweigh the risks.Q: The experience in the West has shown that almost 50% of the patients stop the drug after a year or so. Why does this happen?A: Cost is a disadvantage, especially since there are no generic versions. The other reason is “plateauing”. After a patient loses 10kg, 15kg or 20kg, the drug’s effect plateaus off. In trials, those who stopped taking the drug started gaining weight. In one year, they regained 50% of the weight they lost. In practice, the minute people’s weight starts plateauing after taking the drug for a year or so, they stop as they don’t want to spend money on a drug that has seemingly stopped working.People think diet and exercise will help them, but obesity is complex. It’s not just calories in, calories out. If that was the case, there would be no need for these drugs. All these years people have been trying to lose weight but failed because of the brain: when one starts losing weight, the brain realises that you lost weight and immediately corrects itself trying to regain your weight. The point is that one needs to continue taking the drug to stay on that plateau.Q: New weight-loss drugs came to India only recently. What can we expect next?A: In India, we were waiting for semaglutide and tirzepatide to become available. The injectable forms were delayed until recently, but by March 2026, the patent for semaglutide will expire, allowing generic versions to enter the market. There are over 20 companies that plan to make generic versions available.Companies are now developing a third drug, retatrutide, which targets three hormones: GLP, GIP, and glucagon. It’s in late stages of development and shows promise for even greater weight loss.These drugs offer numerous benefits beyond weight loss, including reduced risk of heart attack, improved kidney function, and potential cognitive benefits. They also help reduce snacking and other addictions, like smoking. One of my patients who was asked to undergo bilateral knee replacement decided to go on weight-loss medication first; he lost 20kg and didn’t need replacement as the knee pain vanished.Q: What are the points to consider before taking up weight-loss drugs?A: One has to consider that when one loses 10kg, it’s not 10kg of fat. It’s 7kg of fat and 3kg of muscle. That means from the little muscle you have, 3kg is going to go. Hence, people get ozempic facies with muscles gone… As your strength will be reduced, one needs to increase protein intake, do some weight training and muscle strength training.End of ArticleFollow Us On Social MediaVideosNitish Kumar To Take CM Oath For Record 10th Time At Patna’s Gandhi Maidan, PM Modi To AttendBangladesh To Seek Interpol’s Help To Extradite Sheikh Hasina From India’Fatwa Issued…’: BJP Jabs ‘Indira Nazi Congress’ For Criticising Tharoor Over Modi Speech PraiseRussia Showcases Missile-Only Pantsir SMD-E Air Defence System At Dubai Airshow 2025’We Hit India…’: Pakistani Leader’s Explosive Admission Unmasks Islamabad’s Terror Links Again’Can’t Rule Out All-Out War’: Pakistan’s Khawaja Asif Rattled Over Army Chief’s Sindoor 2.0 WarningSydney Horror Crash Kills 8-Month Pregnant Indian After Teen BMW Driver Slams Into Family WalkIndia Expands Its Diplomatic Presence In Russia As Jaishankar Highlights Strategic New ConsulatesTaliban Trade Minister Lands in Delhi Amid Major Afghan Shift Toward India After Pakistan ConflictChina’s Propaganda Strike On India Exposed, US Report Details Fake Jet Debris And J-35 Sales Tactics123PhotostoriesKajol’s films that open a quiet doorway back to nineties nostalgia5 national parks to visit in South America for adventure loversAre you eating chia seeds the wrong way? Harvard doctor reveals the 3 healthiest ways to consume them3 Ayurveda-approved drinks to reduce fatty liver naturally10 regional egg dishes from different parts of India5 beautiful white animals that look like furry snowballs8 things life teaches us the hard wayFrom Rajkummar Rao-Patralekhaa to Deepika Padukone-Ranveer Singh: Bollywood’s adorable baby girl squadFrom protection to independence: Smriti Irani’s modern parenting mantraSalman Khan to Shanaya Kapoor: 5 viral looks of the day setting today’s style mood123Hot PicksDelhi AQI TodaySheikh Hasina VerdictBihar Government FormationGold rate todaySilver rate todayPublic Holidays NovemberBank Holidays NovemberTop TrendingTrevon DiggsTom BradyJonathan OwensDraymond GreenPatrick Kane Net Worth 2025Nadia ComaneciAsmongoldFortnite Friday Streamer Awards 2025Stefon DiggsBill Belichick

If you start taking the new weight-loss medications, be ready to stay with it for a long time, says Dr V Mohan, Chennai-based senior diabetologist who has worked extensively on the epidemiology and genetics of the disease. Excerpts from his chat with TOI, which is partnering with Novo Nordisk India to spearhead the ‘Choose Your Weight’ campaign, which aims to change the narrative around obesity.Q: You have watched the evolution of weight-loss drugs through five decades of practice. Did you think they would emerge as such blockbuster drugs?A: Efforts to develop effective weight-reduction medicines have been on for decades. In the late 80s and 90s, drugs such as sibutramine, phentermine and orlistat were introduced that facilitated modest weight loss of 1kg or 2kg, and rarely around 5kg. Some of these drugs had major side-effects and were eventually banned. We, as physicians, began to lose hope that any drug would come along that could offer significant weight loss without significant side-effects.Then, we started getting drugs such as the GLP-1 receptor analogs (GLP-1RAs). Exenatide was the first; it came from the venom of a Gila monster in South America, and ensured significant weight loss than earlier drugs. Initially, we didn’t know how they worked, but they delayed gastric emptying and increased insulin release and glucagon reduction… They work through the potentiation of certain hormones in the intestine called GLP, the glucagon-like peptide. Researchers tried to make glucagon-like peptide itself, but it was very short-acting in the body. So, they started producing GLP-like substances.Exenatide was followed by liraglutide. We found these mainly anti-diabetic drugs offered a two-in-one response by helping people reduce weight. Not everyone responded the same way; some had both weight reduction and HbA1c reduction, others had only one; a small percentage had neither. Then came semaglutide, which took the world by storm. Semaglutide was a weekly injection marketed as Ozempic for diabetes and Wegovy for weight loss. It got approved in the US separately for weight loss and diabetes, marking the first time an anti-diabetic drug was used solely for weight loss. It became a blockbuster drug with billions in sales, and millions started using it due to its unprecedented weight loss results, often 10-15 kg. The drug became so popular that it was hard to find, and new factories had to be built to meet the demand. Celebrities started using it, and before-and-after pictures were circulated widely. They were sold on the black market. This kind of success story with any drug had never been seen in the history of medicine.Q: But there are concerns about their side-effects…A: These drugs, including liraglutide and exenatide, work on the stomach, causing nausea initially. They must be started at a small dose and gradually increased to minimise side-effects. After four to eight weeks, side-effects such as nausea, vomiting, or diarrhoea usually settle.Stomach paralysis is a rare side-effect. Another rare but serious side effect is blindness due to anterior ischemic optic neuropathy. One in 7,000-10,000 people who take these drugs can go blind. Such rare side-effects will surface only when millions start taking a drug. It’s like the Covid vaccination: as mass vaccination was carried out, we saw side-effects. We don’t know why those idiosyncratic reactions occur, but we must remember there’s no big FDA warning so far. Clearly, its benefits far outweigh the risks.Q: The experience in the West has shown that almost 50% of the patients stop the drug after a year or so. Why does this happen?A: Cost is a disadvantage, especially since there are no generic versions. The other reason is “plateauing”. After a patient loses 10kg, 15kg or 20kg, the drug’s effect plateaus off. In trials, those who stopped taking the drug started gaining weight. In one year, they regained 50% of the weight they lost. In practice, the minute people’s weight starts plateauing after taking the drug for a year or so, they stop as they don’t want to spend money on a drug that has seemingly stopped working.People think diet and exercise will help them, but obesity is complex. It’s not just calories in, calories out. If that was the case, there would be no need for these drugs. All these years people have been trying to lose weight but failed because of the brain: when one starts losing weight, the brain realises that you lost weight and immediately corrects itself trying to regain your weight. The point is that one needs to continue taking the drug to stay on that plateau.Q: New weight-loss drugs came to India only recently. What can we expect next?A: In India, we were waiting for semaglutide and tirzepatide to become available. The injectable forms were delayed until recently, but by March 2026, the patent for semaglutide will expire, allowing generic versions to enter the market. There are over 20 companies that plan to make generic versions available.Companies are now developing a third drug, retatrutide, which targets three hormones: GLP, GIP, and glucagon. It’s in late stages of development and shows promise for even greater weight loss.These drugs offer numerous benefits beyond weight loss, including reduced risk of heart attack, improved kidney function, and potential cognitive benefits. They also help reduce snacking and other addictions, like smoking. One of my patients who was asked to undergo bilateral knee replacement decided to go on weight-loss medication first; he lost 20kg and didn’t need replacement as the knee pain vanished.Q: What are the points to consider before taking up weight-loss drugs?A: One has to consider that when one loses 10kg, it’s not 10kg of fat. It’s 7kg of fat and 3kg of muscle. That means from the little muscle you have, 3kg is going to go. Hence, people get ozempic facies with muscles gone… As your strength will be reduced, one needs to increase protein intake, do some weight training and muscle strength training.End of ArticleFollow Us On Social MediaVideosNitish Kumar To Take CM Oath For Record 10th Time At Patna’s Gandhi Maidan, PM Modi To AttendBangladesh To Seek Interpol’s Help To Extradite Sheikh Hasina From India’Fatwa Issued…’: BJP Jabs ‘Indira Nazi Congress’ For Criticising Tharoor Over Modi Speech PraiseRussia Showcases Missile-Only Pantsir SMD-E Air Defence System At Dubai Airshow 2025’We Hit India…’: Pakistani Leader’s Explosive Admission Unmasks Islamabad’s Terror Links Again’Can’t Rule Out All-Out War’: Pakistan’s Khawaja Asif Rattled Over Army Chief’s Sindoor 2.0 WarningSydney Horror Crash Kills 8-Month Pregnant Indian After Teen BMW Driver Slams Into Family WalkIndia Expands Its Diplomatic Presence In Russia As Jaishankar Highlights Strategic New ConsulatesTaliban Trade Minister Lands in Delhi Amid Major Afghan Shift Toward India After Pakistan ConflictChina’s Propaganda Strike On India Exposed, US Report Details Fake Jet Debris And J-35 Sales Tactics123PhotostoriesKajol’s films that open a quiet doorway back to nineties nostalgia5 national parks to visit in South America for adventure loversAre you eating chia seeds the wrong way? Harvard doctor reveals the 3 healthiest ways to consume them3 Ayurveda-approved drinks to reduce fatty liver naturally10 regional egg dishes from different parts of India5 beautiful white animals that look like furry snowballs8 things life teaches us the hard wayFrom Rajkummar Rao-Patralekhaa to Deepika Padukone-Ranveer Singh: Bollywood’s adorable baby girl squadFrom protection to independence: Smriti Irani’s modern parenting mantraSalman Khan to Shanaya Kapoor: 5 viral looks of the day setting today’s style mood123Hot PicksDelhi AQI TodaySheikh Hasina VerdictBihar Government FormationGold rate todaySilver rate todayPublic Holidays NovemberBank Holidays NovemberTop TrendingTrevon DiggsTom BradyJonathan OwensDraymond GreenPatrick Kane Net Worth 2025Nadia ComaneciAsmongoldFortnite Friday Streamer Awards 2025Stefon DiggsBill Belichick

If you start taking the new weight-loss medications, be ready to stay with it for a long time, says Dr V Mohan, Chennai-based senior diabetologist who has worked extensively on the epidemiology and genetics of the disease. Excerpts from his chat with TOI, which is partnering with Novo Nordisk India to spearhead the ‘Choose Your…

Read More
Sushmita Sen turns 50: Former sister-in-law Charu Asopa pens sweet birthday note for her ‘sexy bua’

Sushmita Sen turns 50: Former sister-in-law Charu Asopa pens sweet birthday note for her ‘sexy bua’

Sushmita Sen celebrated her 50th birthday on November 19, 2025, receiving warm wishes from family and celebrities. Her former sister-in-law Charu Asopa shared a loving post calling her “Ziana’s sexy bua” and praised her beauty and grace. Despite divorce, Charu and Rajeev co-parent with mutual respect. Sen remains a Bollywood icon and Miss Universe legend….

Read More
Busting creatine myths: Top cardiologist reveals the truth about this popular fitness supplement |

Busting creatine myths: Top cardiologist reveals the truth about this popular fitness supplement |

When it comes to the world of fitness and health, it can often be confusing. Creatine is widely used by athletes, bodybuilders and daily gym goers. Despite its long-standing reputation in the world of sports and nutrition, creatine is still shrouded in misconceptions. Many people hesitate to consume creatine because of the myths that simply…

Read More
Pearls before swine: Trump pigs out on epithets

Pearls before swine: Trump pigs out on epithets

TOI correspondent from Washington: Growing tensions between the Trump White House and the largely liberal Washington press corps reached a flashpoint this week after the MAGA boss directed a crude insult toward a female journalist and threatened to revoke the license of a broadcast network whose reporter asked him tough questions.The first episode unfolded on…

Read More
NEW DELHI : The Supreme Court has granted interim bail to social activist Jyoti Jagtap in the Elgar Parishad case.A bench of Justices M M Sundresh and Satish Chandra Sharma on Wednesday granted her the relief till the next date of hearing in Feb next year, after senior advocate Aparna Bhat told the court that the activist has been in jail for more than five years.According to NIA chargesheet, speeches given by the accused at Elgar Parishad contributed to violence at Koregaon Bhima near Pune. Jagtap, along with 16 others, is accused by NIA of being responsible for the caste violence. She was alleged to be a member of the Kabir Kala Manch, one of the organisers of the Elgar Parishad. Jagtap was arrested on Sept 8, 2020, by the NIA and was chargesheeted on Oct 9, 2020.HC rejected bail plea in Oct 2022Social activist Jyoti Jagtap approached SC after the Bombay HC rejected her bail plea in Oct 2022.The same bench had in Sept granted six-week interim bail on medical grounds to Elgar Parishad co-accused Mahesh Raut, who was arrested in 2018, and later extended it till the next hearing. Raut had been granted bail by the Bombay high court in Sept 2023, but the apex court stayed that order, preventing his release. Last month, however, interim relief was granted to him.End of ArticleFollow Us On Social MediaVideosNitish Kumar To Take CM Oath For Record 10th Time At Patna’s Gandhi Maidan, PM Modi To AttendBangladesh To Seek Interpol’s Help To Extradite Sheikh Hasina From India’Fatwa Issued…’: BJP Jabs ‘Indira Nazi Congress’ For Criticising Tharoor Over Modi Speech PraiseRussia Showcases Missile-Only Pantsir SMD-E Air Defence System At Dubai Airshow 2025’We Hit India…’: Pakistani Leader’s Explosive Admission Unmasks Islamabad’s Terror Links Again’Can’t Rule Out All-Out War’: Pakistan’s Khawaja Asif Rattled Over Army Chief’s Sindoor 2.0 WarningSydney Horror Crash Kills 8-Month Pregnant Indian After Teen BMW Driver Slams Into Family WalkIndia Expands Its Diplomatic Presence In Russia As Jaishankar Highlights Strategic New ConsulatesTaliban Trade Minister Lands in Delhi Amid Major Afghan Shift Toward India After Pakistan ConflictChina’s Propaganda Strike On India Exposed, US Report Details Fake Jet Debris And J-35 Sales Tactics123PhotostoriesKajol’s films that open a quiet doorway back to nineties nostalgia5 national parks to visit in South America for adventure loversAre you eating chia seeds the wrong way? Harvard doctor reveals the 3 healthiest ways to consume them3 Ayurveda-approved drinks to reduce fatty liver naturally10 regional egg dishes from different parts of India5 beautiful white animals that look like furry snowballs8 things life teaches us the hard wayFrom Rajkummar Rao-Patralekhaa to Deepika Padukone-Ranveer Singh: Bollywood’s adorable baby girl squadFrom protection to independence: Smriti Irani’s modern parenting mantraSalman Khan to Shanaya Kapoor: 5 viral looks of the day setting today’s style mood123Hot PicksDelhi AQI TodaySheikh Hasina VerdictBihar Government FormationGold rate todaySilver rate todayPublic Holidays NovemberBank Holidays NovemberTop TrendingTrevon DiggsTom BradyJonathan OwensDraymond GreenPatrick Kane Net Worth 2025Nadia ComaneciAsmongoldFortnite Friday Streamer Awards 2025Stefon DiggsBill Belichick

NEW DELHI : The Supreme Court has granted interim bail to social activist Jyoti Jagtap in the Elgar Parishad case.A bench of Justices M M Sundresh and Satish Chandra Sharma on Wednesday granted her the relief till the next date of hearing in Feb next year, after senior advocate Aparna Bhat told the court that the activist has been in jail for more than five years.According to NIA chargesheet, speeches given by the accused at Elgar Parishad contributed to violence at Koregaon Bhima near Pune. Jagtap, along with 16 others, is accused by NIA of being responsible for the caste violence. She was alleged to be a member of the Kabir Kala Manch, one of the organisers of the Elgar Parishad. Jagtap was arrested on Sept 8, 2020, by the NIA and was chargesheeted on Oct 9, 2020.HC rejected bail plea in Oct 2022Social activist Jyoti Jagtap approached SC after the Bombay HC rejected her bail plea in Oct 2022.The same bench had in Sept granted six-week interim bail on medical grounds to Elgar Parishad co-accused Mahesh Raut, who was arrested in 2018, and later extended it till the next hearing. Raut had been granted bail by the Bombay high court in Sept 2023, but the apex court stayed that order, preventing his release. Last month, however, interim relief was granted to him.End of ArticleFollow Us On Social MediaVideosNitish Kumar To Take CM Oath For Record 10th Time At Patna’s Gandhi Maidan, PM Modi To AttendBangladesh To Seek Interpol’s Help To Extradite Sheikh Hasina From India’Fatwa Issued…’: BJP Jabs ‘Indira Nazi Congress’ For Criticising Tharoor Over Modi Speech PraiseRussia Showcases Missile-Only Pantsir SMD-E Air Defence System At Dubai Airshow 2025’We Hit India…’: Pakistani Leader’s Explosive Admission Unmasks Islamabad’s Terror Links Again’Can’t Rule Out All-Out War’: Pakistan’s Khawaja Asif Rattled Over Army Chief’s Sindoor 2.0 WarningSydney Horror Crash Kills 8-Month Pregnant Indian After Teen BMW Driver Slams Into Family WalkIndia Expands Its Diplomatic Presence In Russia As Jaishankar Highlights Strategic New ConsulatesTaliban Trade Minister Lands in Delhi Amid Major Afghan Shift Toward India After Pakistan ConflictChina’s Propaganda Strike On India Exposed, US Report Details Fake Jet Debris And J-35 Sales Tactics123PhotostoriesKajol’s films that open a quiet doorway back to nineties nostalgia5 national parks to visit in South America for adventure loversAre you eating chia seeds the wrong way? Harvard doctor reveals the 3 healthiest ways to consume them3 Ayurveda-approved drinks to reduce fatty liver naturally10 regional egg dishes from different parts of India5 beautiful white animals that look like furry snowballs8 things life teaches us the hard wayFrom Rajkummar Rao-Patralekhaa to Deepika Padukone-Ranveer Singh: Bollywood’s adorable baby girl squadFrom protection to independence: Smriti Irani’s modern parenting mantraSalman Khan to Shanaya Kapoor: 5 viral looks of the day setting today’s style mood123Hot PicksDelhi AQI TodaySheikh Hasina VerdictBihar Government FormationGold rate todaySilver rate todayPublic Holidays NovemberBank Holidays NovemberTop TrendingTrevon DiggsTom BradyJonathan OwensDraymond GreenPatrick Kane Net Worth 2025Nadia ComaneciAsmongoldFortnite Friday Streamer Awards 2025Stefon DiggsBill Belichick

NEW DELHI : The Supreme Court has granted interim bail to social activist Jyoti Jagtap in the Elgar Parishad case.A bench of Justices M M Sundresh and Satish Chandra Sharma on Wednesday granted her the relief till the next date of hearing in Feb next year, after senior advocate Aparna Bhat told the court that…

Read More
Sub-Rs 10L cars make up 78% of festive sales

Sub-Rs 10L cars make up 78% of festive sales

CHENNAI: Rationalised GST rates and buoyant festive sentiment have propelled demand in the industry’s ‘bread-and-butter’ sub-Rs 10 lakh segment to multi-year highs, amid an ongoing premiumisation wave in the country. The reset in tax slabs – particularly for small cars and compact SUVs – widened affordability and revived interest among price-conscious buyers who had been…

Read More
‘The Girlfriend’ actor Dheekshith Shetty had this EPIC response when asked about co-star Rashmika Mandanna’s love life with Vijay Deverakonda

‘The Girlfriend’ actor Dheekshith Shetty had this EPIC response when asked about co-star Rashmika Mandanna’s love life with Vijay Deverakonda

While promoting his new film ‘Bank of Bhagyalakshmi’, Dheekshith Shetty, who stars alongside Rashmika Mandanna in ‘The Girlfriend’, faced numerous inquiries about her alleged romance with Vijay Deverakonda. He maintained a respectful stance on personal boundaries, asserting that he isn’t privy to Mandanna’s private affairs and their discussions are solely focused on their cinematic endeavors….

Read More
Leo Daily Horoscope Today, November 20, 2025: Destiny is rearranging itself in your favour, but only if you move with it

Leo Daily Horoscope Today, November 20, 2025: Destiny is rearranging itself in your favour, but only if you move with it

Today will ask you to slow down and listen to what your heart is truly saying. Instead of reacting quickly, try to feel first and respond with awareness. There may be emotional waves passing through, and while your natural instinct might be to control or push forward, it’s better to pause. Inner clarity is stronger…

Read More
Nvidia Q3 results: Chipmaker giant reports 65% jump in net income; beats analyst predictions

Nvidia Q3 results: Chipmaker giant reports 65% jump in net income; beats analyst predictions

AI chip giant Nvidia on Wednesday reported profit of $31.9 billion and record high $57 billion quarterly revenue, surging beyond the bar set by stock market projections, potentially easing AI bubble fears.Investors closely watched as chipmaker Nvidia released its quarterly earnings amid the backdrop of AI bubble concerns.“Blackwell sales are off the charts, and cloud…

Read More
The Supreme Court has declared the Tribunal Reforms Act unconstitutional, criticizing the government’s repeated attempts to undermine tribunal independence. A bench led by CJI Gavai found the Act to be a near-replica of a previously struck-down ordinance, violating separation of powers and judicial independence. This ruling emphasizes constitutional supremacy over parliamentary discretion.  NEW DELHI: Supreme Court struck down Wednesday the Tribunal Reforms Act as unconstitutional and slammed the central govt for its repeated attempts to override SC’s consistent rulings to shield the judicial independence of tribunals, which decide disputes in a gamut of regimes – taxation, environment, electricity, telecom and real estate. Days before his retirement, a CJI B R Gavai-led bench deprecated the Centre’s repeated attempts to tinker with the qualifications, tenure and service conditions for chairpersons and members of the tribunals and took umbrage that within weeks of SC striking down the Tribunal Reforms Ordinance in July 2021, the govt tabled a bill in Parliament to enact the law whose provisions were identical to that of the ordinance. Censuring the govt for “consciously attempting to annul the rulings” by enacting a law that had “cosmetically changed a few provisions” of the annulled law, the bench of CJI Gavai and Justice K Vinod Chandran said, “The Tribunal Reforms Act, 2021 is a replica of the struck-down ordinance; old wine in a new bottle, the wine whets not the judicial palate, but the bottle merely dazzles.” The verdict means that, pending the enactment of a new law, the service conditions of tribunal presidents and members would be governed by their parent Acts. For example, ITAT Act would govern service conditions of ITAT president and members. Writing the judgment, CJI Gavai said, “The provisions of the impugned Act cannot be sustained. They violate the constitutional principles of separation of powers and judicial independence.” SC: Parl’s discretion broad, not absolute  The Supreme Court said the Act directly contradicts binding judicial pronouncements that have repeatedly clarified the standards governing the appointment, tenure and functioning of tribunal members. The bench said that the Act, which intended to usher in uniformity in tenure and service conditions of all tribunal members, undermined the constitutional requirements of independence and impartiality of tribunals by enabling the executive to exercise control over them.The Supreme Court said, “Where Parliament reenacts provisions previously struck down without curing the underlying defect, the resulting legislation remains vulnerable to invalidation, not because the Court is imposing its own policy, but because the Constitution itself demands adherence to these structural safeguards.””The Indian constitutional framework does not subscribe to parliamentary sovereignty, nor does it vest unqualified supremacy in the judiciary. “The architecture of our Constitution is firmly rooted in the principle of constitutional supremacy.”It said that when SC interprets the Constitution and pronounces upon the validity of a law, that pronouncement becomes the authoritative and binding declaration of the law.”Once the court has struck down a provision or issued binding directions after identifying a constitutional defect, Parliament cannot simply override or contradict that judicial decision by re-enacting the very same measure in a different form,” CJI Gavai said.Supreme Court said Parliament’s discretion is broad but not absolute.End of ArticleFollow Us On Social MediaVideosNitish Kumar To Take CM Oath For Record 10th Time At Patna’s Gandhi Maidan, PM Modi To AttendBangladesh To Seek Interpol’s Help To Extradite Sheikh Hasina From India’Fatwa Issued…’: BJP Jabs ‘Indira Nazi Congress’ For Criticising Tharoor Over Modi Speech PraiseRussia Showcases Missile-Only Pantsir SMD-E Air Defence System At Dubai Airshow 2025’We Hit India…’: Pakistani Leader’s Explosive Admission Unmasks Islamabad’s Terror Links Again’Can’t Rule Out All-Out War’: Pakistan’s Khawaja Asif Rattled Over Army Chief’s Sindoor 2.0 WarningSydney Horror Crash Kills 8-Month Pregnant Indian After Teen BMW Driver Slams Into Family WalkIndia Expands Its Diplomatic Presence In Russia As Jaishankar Highlights Strategic New ConsulatesTaliban Trade Minister Lands in Delhi Amid Major Afghan Shift Toward India After Pakistan ConflictChina’s Propaganda Strike On India Exposed, US Report Details Fake Jet Debris And J-35 Sales Tactics123PhotostoriesKajol’s films that open a quiet doorway back to nineties nostalgia5 national parks to visit in South America for adventure loversAre you eating chia seeds the wrong way? Harvard doctor reveals the 3 healthiest ways to consume them3 Ayurveda-approved drinks to reduce fatty liver naturally10 regional egg dishes from different parts of India5 beautiful white animals that look like furry snowballs8 things life teaches us the hard wayFrom Rajkummar Rao-Patralekhaa to Deepika Padukone-Ranveer Singh: Bollywood’s adorable baby girl squadFrom protection to independence: Smriti Irani’s modern parenting mantraSalman Khan to Shanaya Kapoor: 5 viral looks of the day setting today’s style mood123Hot PicksDelhi AQI TodaySheikh Hasina VerdictBihar Government FormationGold rate todaySilver rate todayPublic Holidays NovemberBank Holidays NovemberTop TrendingTrevon DiggsTom BradyJonathan OwensDraymond GreenPatrick Kane Net Worth 2025Nadia ComaneciAsmongoldFortnite Friday Streamer Awards 2025Stefon DiggsBill Belichick

The Supreme Court has declared the Tribunal Reforms Act unconstitutional, criticizing the government’s repeated attempts to undermine tribunal independence. A bench led by CJI Gavai found the Act to be a near-replica of a previously struck-down ordinance, violating separation of powers and judicial independence. This ruling emphasizes constitutional supremacy over parliamentary discretion. NEW DELHI: Supreme Court struck down Wednesday the Tribunal Reforms Act as unconstitutional and slammed the central govt for its repeated attempts to override SC’s consistent rulings to shield the judicial independence of tribunals, which decide disputes in a gamut of regimes – taxation, environment, electricity, telecom and real estate. Days before his retirement, a CJI B R Gavai-led bench deprecated the Centre’s repeated attempts to tinker with the qualifications, tenure and service conditions for chairpersons and members of the tribunals and took umbrage that within weeks of SC striking down the Tribunal Reforms Ordinance in July 2021, the govt tabled a bill in Parliament to enact the law whose provisions were identical to that of the ordinance. Censuring the govt for “consciously attempting to annul the rulings” by enacting a law that had “cosmetically changed a few provisions” of the annulled law, the bench of CJI Gavai and Justice K Vinod Chandran said, “The Tribunal Reforms Act, 2021 is a replica of the struck-down ordinance; old wine in a new bottle, the wine whets not the judicial palate, but the bottle merely dazzles.” The verdict means that, pending the enactment of a new law, the service conditions of tribunal presidents and members would be governed by their parent Acts. For example, ITAT Act would govern service conditions of ITAT president and members. Writing the judgment, CJI Gavai said, “The provisions of the impugned Act cannot be sustained. They violate the constitutional principles of separation of powers and judicial independence.” SC: Parl’s discretion broad, not absolute The Supreme Court said the Act directly contradicts binding judicial pronouncements that have repeatedly clarified the standards governing the appointment, tenure and functioning of tribunal members. The bench said that the Act, which intended to usher in uniformity in tenure and service conditions of all tribunal members, undermined the constitutional requirements of independence and impartiality of tribunals by enabling the executive to exercise control over them.The Supreme Court said, “Where Parliament reenacts provisions previously struck down without curing the underlying defect, the resulting legislation remains vulnerable to invalidation, not because the Court is imposing its own policy, but because the Constitution itself demands adherence to these structural safeguards.””The Indian constitutional framework does not subscribe to parliamentary sovereignty, nor does it vest unqualified supremacy in the judiciary. “The architecture of our Constitution is firmly rooted in the principle of constitutional supremacy.”It said that when SC interprets the Constitution and pronounces upon the validity of a law, that pronouncement becomes the authoritative and binding declaration of the law.”Once the court has struck down a provision or issued binding directions after identifying a constitutional defect, Parliament cannot simply override or contradict that judicial decision by re-enacting the very same measure in a different form,” CJI Gavai said.Supreme Court said Parliament’s discretion is broad but not absolute.End of ArticleFollow Us On Social MediaVideosNitish Kumar To Take CM Oath For Record 10th Time At Patna’s Gandhi Maidan, PM Modi To AttendBangladesh To Seek Interpol’s Help To Extradite Sheikh Hasina From India’Fatwa Issued…’: BJP Jabs ‘Indira Nazi Congress’ For Criticising Tharoor Over Modi Speech PraiseRussia Showcases Missile-Only Pantsir SMD-E Air Defence System At Dubai Airshow 2025’We Hit India…’: Pakistani Leader’s Explosive Admission Unmasks Islamabad’s Terror Links Again’Can’t Rule Out All-Out War’: Pakistan’s Khawaja Asif Rattled Over Army Chief’s Sindoor 2.0 WarningSydney Horror Crash Kills 8-Month Pregnant Indian After Teen BMW Driver Slams Into Family WalkIndia Expands Its Diplomatic Presence In Russia As Jaishankar Highlights Strategic New ConsulatesTaliban Trade Minister Lands in Delhi Amid Major Afghan Shift Toward India After Pakistan ConflictChina’s Propaganda Strike On India Exposed, US Report Details Fake Jet Debris And J-35 Sales Tactics123PhotostoriesKajol’s films that open a quiet doorway back to nineties nostalgia5 national parks to visit in South America for adventure loversAre you eating chia seeds the wrong way? Harvard doctor reveals the 3 healthiest ways to consume them3 Ayurveda-approved drinks to reduce fatty liver naturally10 regional egg dishes from different parts of India5 beautiful white animals that look like furry snowballs8 things life teaches us the hard wayFrom Rajkummar Rao-Patralekhaa to Deepika Padukone-Ranveer Singh: Bollywood’s adorable baby girl squadFrom protection to independence: Smriti Irani’s modern parenting mantraSalman Khan to Shanaya Kapoor: 5 viral looks of the day setting today’s style mood123Hot PicksDelhi AQI TodaySheikh Hasina VerdictBihar Government FormationGold rate todaySilver rate todayPublic Holidays NovemberBank Holidays NovemberTop TrendingTrevon DiggsTom BradyJonathan OwensDraymond GreenPatrick Kane Net Worth 2025Nadia ComaneciAsmongoldFortnite Friday Streamer Awards 2025Stefon DiggsBill Belichick

NEW DELHI: Supreme Court struck down Wednesday the Tribunal Reforms Act as unconstitutional and slammed the central govt for its repeated attempts to override SC’s consistent rulings to shield the judicial independence of tribunals, which decide disputes in a gamut of regimes – taxation, environment, electricity, telecom and real estate. Days before his retirement, a…

Read More